AEHR TEST SYSTEMS WKN: 908802 ISIN: US00760J1088 Kürzel: AYB Forum: Aktien Thema: Hauptdiskussion

Ich bin auch raus. Der Backlog mega schlecht und die Zahlen auch. So sieht kein starkes Unternehmen aus. 22 % Minus.

Ich bin raus hier mit 60% Minus. Euch noch viel Glück

FREMONT, CA / ACCESSWIRE / March 25, 2024 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced preliminary financial results for its third quarter of fiscal 2024 ended February 29, 2024. Preliminary results reflect delays in wafer level burn-in system orders for semiconductor devices used in electric vehicles that have created a short-term gap in revenue and profitability. Additionally, Aehr provided updated revenue guidance for its full fiscal year ending May 31, 2024. For the fiscal third quarter ended February 29, 2024, Aehr expects: Revenue of approximately $7.6 million GAAP net loss of approximately $1.5 million to $1.8 million, or $0.05 to $0.06 per diluted share Non-GAAP net loss of approximately $0.9 million to $1.2 million, or $0.03 to $0.04 per diluted share, which excludes the impact of stock-based compensation Bookings of $24.5 million Backlog as of February 29, 2024, of $20 million For the fiscal 2024 full year ending May 31, 2024, Aehr expects: Total revenue of at least $65 million GAAP net income of approximately $11 million or more, or $0.38 per diluted share Non-GAAP net income of approximately $14 million or more, or $0.48 per diluted share, which excludes the impact of stock-based compensation An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr's non-GAAP financial measures to the most directly comparable GAAP financial measures will be included when Aehr releases its full financial results for the fiscal 2024 third quarter on April 9, 2024. Aehr Test Systems President and CEO Gayn Erickson commented: "As we discussed in our second quarter earnings call, we had seen several push outs of forecasted orders by current and new customers that impacted our fiscal year revenue. We believe that this was due to two key factors. There is clearly softness in the overall semiconductor capital spending, particularly in automotive applications, related to a glut in inventory driving down near-term orders to these companies and has caused them to push out capital spending and drive cost reductions. Multiple companies including the companies we had expected orders from have publicly discussed inventory related headwinds in their public earnings calls and press releases. In addition, we have seen specific shifts in order timing of our equipment used for wafer level test and burn-in of silicon carbide power semiconductors used in electric vehicles. In just the last two weeks of the quarter, we saw delays in orders for silicon carbide systems with customer-requested ship dates within the quarter as well as a last-minute push out by a customer of a system in our backlog. The net effect of this was a significant shift in revenues out of the third and fourth quarters. Until this time, we had been hearing from those customers that their silicon carbide-based capital investments were not being impacted.

Uff. Die Zahlen sind ja mega schlecht zur Guidance.

Oh man

hat sich erledigt

Bei mir steht 28.03? Hat jemand anderes Ahnung?

bin gespannt ob wir heute über die 15,00$ schließen

am 04.04.2024 kommen die Q-Zahlen

da kenne ich aber andere Aktien........alles gut hier.

KGV 20 ist okay

Heute habe ich verkauft. Aktie ist immer noch überbewertet.

Siet einem Jahr nicht mehr reingeschaut. Was waren die Gründe für den Absturz?

Ouh das tut sehr sehr weh……

Was für ne geile Aktie. Nächster Halt: 12€.

Rollercoaster eben